Metformin
Chiglitazar
Shengjing HospitalSmall moleculePhase 2/3Active
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Chiglitazar cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Letrozole Shengjing Hospital | Phase 2/3 | B |
Chiglitazar Shengjing Hospital | Phase 2/3 | B |
Same molecule, other indications
Metformin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →